Kitabis Pak Approval History
FDA Approved: Yes (First approved December 2, 2014)
Brand name: Kitabis Pak
Generic name: tobramycin
Dosage form: Inhalation Solution
Company: PulmoFlow, Inc.
Treatment for: Cystic Fibrosis
Kitabis Pak (tobramycin) is an aminoglycoside inhalation solution co-packaged with a PARI LC PLUS® Reusable Nebulizer for the management of cystic fibrosis.
Development History and FDA Approval Process for Kitabis Pak
|Dec 3, 2014||FDA Approves PulmoFlow's Kitabis Pak Tobramycin & Nebulizer Combination for Cystic Fibrosis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.